z-logo
open-access-imgOpen Access
Ceftazidime nephrotoxicity in rats
Author(s) -
Friedrich C. Luft,
D W Visscher,
D.M. Nierste,
D K Blase,
N Walker,
George R. Aronoff
Publication year - 1984
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.25.4.513
Subject(s) - ceftazidime , nephrotoxicity , tobramycin , cefazolin , cephaloridine , medicine , pharmacology , antibiotics , chemistry , cephalosporin , kidney , gentamicin , biology , biochemistry , bacteria , genetics , pseudomonas aeruginosa
The nephrotoxicity of ceftazidime compared with that of cefazolin or cephaloridine and the capacity of ceftazidime to enhance the nephrotoxicity of tobramycin were evaluated in rats. Only cephaloridine and tobramycin given alone altered creatinine clearance or caused significant histological injury. Our data suggest that ceftazidime is no more nephrotoxic than cefazolin and does not enhance the nephrotoxicity of tobramycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom